Paid Clinical Trials in Kansas

Kansas has 884 paid clinical trials enrolling now across cities including Kansas City, Overland Park and Westwood. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

798 clinical trials

Get a weekly email when new trials open in Kansas City, KS.

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

for B-cell Lymphoma

Sites in Westwood +3 more locations

Sponsor: CRISPR Therapeutics AG

Sex: All·Age: 18+

Code: NCT05643742·Phase 1, Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

for Relapsed or Resistant Acute Leukaemias

Sites in Fairway +4 more locations

Sponsor: Lin BioScience, Inc

Sex: All·Age: 18 - 120

Code: NCT05756322·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

for Acute Myeloid Leukemia, in Relapse

Sites in Kansas City +2 more locations

Sponsor: Marker Therapeutics, Inc.

Sex: All·Age: 65+

Code: NCT06552416·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

for Non-Hodgkin Lymphoma, Adult

Sites in Kansas City +6 more locations

Sponsor: Marker Therapeutics, Inc.

Sex: All·Age: 18 - 100

Code: NCT05798897·Phase 1·Recruiting·Listed Apr 2023

Apply to this trial

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Sites in Kansas City +8 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06538064·Recruiting·Listed Aug 2024

Apply to this trial

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

for Fabry Disesase

Sites in Kansas City +5 more locations

Sponsor: GC Biopharma Corp

Sex: All·Age: 18+

Code: NCT06858397·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

for Healthy Participants

Sites in Lenexa +1 more location

Sponsor: Shionogi

Sex: Male·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07093580·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device

for Degenerative Conditions of the Lumbar Spine

Sites in Kansas City +5 more locations

Sponsor: Spinal Simplicity LLC

Sex: All·Age: 18+

Code: NCT06355791·Recruiting·Listed Apr 2024

Apply to this trial

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

for Acute Myeloid Leukemia (AML)

Drug: Venetoclax

Sites in Fairway +5 more locations

Sponsor: Bio-Path Holdings, Inc.

Sex: All·Age: 18+

Code: NCT02781883·Phase 2·Recruiting·Listed May 2016

Apply to this trial

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

for Cystic Fibrosis

Sites in Kansas City +3 more locations

Sponsor: Spirovant Sciences, Inc.

Sex: All·Age: 18 - 65

Code: NCT06526923·Phase 1, Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

for Acute Myeloid Leukemia (AML)

Sites in Fairway +6 more locations

Sponsor: Aptevo Therapeutics

Sex: All·Age: 18+

Code: NCT06634394·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

Study of Student Flourishing

for Healthy

Sites in Manhattan +8 more locations

Sponsor: Flourish Science, Inc.

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07259746·Recruiting·Listed Dec 2025

Apply to this trial

Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

for DMD-Associated Dilated Cardiomyopathy

Sites in Kansas City +2 more locations

Sponsor: Sardocor Corp.

Sex: Male·Age: 18+

Code: NCT06224660·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

for Acute Myeloid Leukemia

Sites in Kansas City +2 more locations

Sponsor: GluBio Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06146257·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

Lumbar & Sacroiliac Fusion Study Involving Previously Implanted Devices

for Fusion of Spine

Sites in Overland Park +2 more locations

Sponsor: Spinal Simplicity LLC

Sex: All·Age: 18+

Code: NCT07204288·Recruiting·Listed Oct 2025

Apply to this trial

A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers

for Thromboangiitis Obliterans (Buerger's Disease)

1 location in Overland Park

Sponsor: Antidote Therapeutics, Inc

Sex: All·Age: 23 - 59·Accepts healthy volunteers

Code: NCT07215923·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

Abuse Liability for Five Modern Oral Nicotine Products

for Smoking

1 location in Overland Park

Sponsor: RAI Services Company

Sex: All·Age: 21 - 60·Accepts healthy volunteers

Code: NCT07132814·Recruiting·Listed Aug 2025

Apply to this trial

The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

for Lower Respiratory Tract Infection

Sites in Kansas City +7 more locations

Sponsor: MeMed Diagnostics Ltd.

Sex: All·Age: 18 - 99

Code: NCT05762302·Recruiting·Listed Mar 2023

Apply to this trial

A Study of IBI3032 in Healthy Participants

for Healthy

1 location in Lenexa

Sponsor: Fortvita Biologics (USA)Inc.

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07120425·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

for Advanced EGFR Positive Solid Tumor

Sites in Fairway +2 more locations

Sponsor: Changchun Intellicrown Pharmaceutical Co. LTD

Sex: All·Age: 18+

Code: NCT04412616·Phase 1·Recruiting·Listed Jun 2020

Apply to this trial

A Study of IBI363 in Subjects with Advanced Solid Malignancies

for Melanoma

Sites in Fairway +8 more locations

Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All·Age: 18+

Code: NCT06281678·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

ProACT Post-Approval Study

for Stress Urinary Incontinence

Sites in Kansas City +5 more locations

Sponsor: Uromedica

Sex: Male·Age: 50+·Accepts healthy volunteers

Code: NCT03767595·Recruiting·Listed Dec 2018

Apply to this trial

Encore PFO Closure Device - The PerFOrm Trial

for Patent Foramen Ovale

Sites in Kansas City +7 more locations

Sponsor: Encore Medical Inc.

Sex: All·Age: 18 - 60

Code: NCT05537753·Recruiting·Listed Sep 2022

Apply to this trial

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

for Acute Myeloid Leukemia

Sites in Fairway +1 more location

Sponsor: Celyad Oncology SA

Sex: All·Age: 18+

Code: NCT04167696·Phase 1·Recruiting·Listed Nov 2019

Apply to this trial

Changes in Body Composition Including Muscle With Anti-Obesity Medications, Both With and Without Exercise

for Obesity & Overweight

1 location in Kansas City

Sponsor: University of Kansas Medical Center

Sex: All·Age: 18 - 64

Code: NCT07698145·Recruiting·Listed Jul 2026

Apply to this trial

Collaboration for Down Syndrome Progress (CDP)

for Down Syndrome

Sites in Kansas City +15 more locations

Sponsor: RTI International

Sex: All·Age: All ages

Code: NCT07625579·Recruiting·Listed Jun 2026

Apply to this trial

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

for Sudan Virus Disease

Sites in Lenexa +2 more locations

Sponsor: International AIDS Vaccine Initiative

Sex: All·Age: 18 - 50·Accepts healthy volunteers

Code: NCT07565090·Phase 1·Recruiting·Listed May 2026

Apply to this trial

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

for Anatomic Stage II Breast Cancer AJCC v8

Drug: Ribociclib

Sites in Kansas City, Overland Park +171 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07391774·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Maternal Intake of Eggs and Infant Neurodevelopment

for Pregnancy Related

1 location in Kansas City

Sponsor: University of Kansas Medical Center

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT07583186·Recruiting·Listed May 2026

Apply to this trial

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for Chronic Lymphocytic Leukemia

Drug: Sonrotoclax

Sites in Kansas City, Overland Park +204 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 65+

Code: NCT07321652·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

for Ampulla of Vater Carcinoma

Sites in Kansas City, Overland Park +346 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07283939·Recruiting·Listed Dec 2025

Apply to this trial

My Path to Quit Tobacco

for Smoking Cessation

Sites in Kansas City +4 more locations

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 21+·Accepts healthy volunteers

Code: NCT07419425·Phase 4·Recruiting·Listed Feb 2026

Apply to this trial

Adapting RDAD for DS

for Down Syndrome (DS)

1 location in Kansas City

Sponsor: University of Kansas Medical Center

Sex: All·Age: All ages

Code: NCT07425769·Recruiting·Listed Feb 2026

Apply to this trial

Preliminary Effectiveness of Enhanced Text Message + Incentives

for Smoking Cessation

1 location in Kansas City

Sponsor: University of Kansas Medical Center

Sex: Female·Age: 18+

Code: NCT07420621·Recruiting·Listed Feb 2026

Apply to this trial

Using Transcranial Magnetic Stimulation to Treat Stuttering

for Stuttering, Adult

1 location in Manhattan

Sponsor: Kansas State University

Sex: All·Age: 18 - 65

Code: NCT07389694·Recruiting·Listed Feb 2026

Apply to this trial

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

for Breast Cancer

Sites in Kansas City, Overland Park +1087 more locations

Sponsor: NRG Oncology

Sex: Female·Age: 18 - 60

Code: NCT05879926·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

for Lung Non-Small Cell Carcinoma

Sites in Wichita, Olathe +625 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04267848·Phase 3·Recruiting·Listed Feb 2020

Apply to this trial

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

for Stage III Colon Cancer

Sites in Overland Park, Wichita +923 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT05174169·Phase 2, Phase 3·Recruiting·Listed Dec 2021

Apply to this trial

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for Intracranial Meningioma

Sites in Pittsburg, Great Bend +446 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT02523014·Phase 2·Recruiting·Listed Aug 2015

Apply to this trial

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

for Advanced Esophageal Adenocarcinoma

Drug: Nivolumab

Sites in Topeka, Lawrence +626 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT05677490·Phase 3·Recruiting·Listed Jan 2023

Apply to this trial